Does graft-versus-host disease attack epithelial stem cells?

Molecular Medicine Today

Volumn 2, Issue 3, 1996, Pages 114-119

  Sale, George E ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 2;

ANIMAL; CYTOTOXIC T LYMPHOCYTE; GRAFT VERSUS HOST REACTION; HUMAN; IMMUNOLOGY; NATURAL KILLER CELL; NEOPLASM; PATHOLOGY; REVIEW; STEM CELL;

ANIMALS; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; KILLER CELLS, NATURAL; NEOPLASMS; STEM CELLS; T-LYMPHOCYTES, CYTOTOXIC;

EID: 0030097193     PISSN: 13574310     EISSN: None     Source Type: Journal    
DOI: 10.1016/1357-4310(96)88721-1     Document Type: Review

References (32)

1. Billingham, R.E. (1966-1967) The biology of graft vs host reaction, Harvey Lectures 52, 21-78
2. Seemayer, T.A. (1979) The GvHR: a pathogenetic mechanism of experimental and human disease, in Perspectives in Pediatric Pathology (Vol. 5) (Rosenberg, H.S. and Bolande, R.P., eds), pp. 93-136, Masson Publishing
3. Burakoff, S., Deeg, H.J., Ferrara, J. and Atkinson, K., eds (1990) Graft vs Host Disease: Immunology, Pathophysiology and Treatment, Marcel Dekker
4. Deeg, H.J. and Cottler-Fox, M. (1990) Clinical spectrum and pathophysiology of GvHD, in Graft vs Host Disease: Immunology, Pathophysiology and Treatment (Burakoff, S., Deeg, H.J., Ferrara, J. and Atkinson, K., eds), pp. 311-336, Marcel Dekker
5. Hess, A.D. (1990) Syngeneic graft vs host disease, in Graft vs Host Disease: Immunology, Pathophysiology and Treatment (Burakoff, S., Deeg, H.J., Ferrara, J. and Atkinson, K., eds), pp. 95-108, Marcel Dekker
6. Gaspari, A.A. et al. (1987) Dermatologie changes associated with interleukin 2 administration, J. Am. Med. Assoc. 258, 1624-1629
7. van Bekkum, D.W. and de Vries, M.J. (1967) Radiation Chimeras, Logos
8. Lowin, B., Hahne, M., Mattmann, C. and Tschopp, J. (1994) Cytolytic T cell cytotoxicity is mediated through perform and Fas lytic pathways, Nature 370, 650-652
9. Sale, G.E. et al. (1987) Direct ultrastructural evidence of target-directed polarization by cytotoxic lymphocytes in lesions of human graft-versus-host disease, Arch. Pathol. Lab. Med. 111, 333-336
10. Sale, G.E., Anderson, P., Browne, M. and Myerson, D. (1992) Evidence of cytotoxic T-cell destruction of epidermal cells in human graft-versus-host disease: immunohistology with monoclonal antibody TIA-1, Arch. Path. Lab. Med. 116, 622-625
11. Sale, G.E., Beauchamp, M. and Myerson, D. (1994) Immunohistologic staining of cytotoxic T- and NK-cells in formalin-fixed paraffin-embedded tissue using microwave TIA-1 antigen retrieval, Transplantation 57, 287-289
12. Lavker, R.M. and Sun, T.T. (1982) Heterogeneity in epidermal basal keratinocytes: morphological and functional correlations, Science 215, 1239-1241
13. Sale, G.E., Shulman, H.M., Gallucci, B.B. and Thomas, E.D. (1985) Young rete ridge keratinocytes are preferred targets in cutaneous graft-versus-host disease, Am. J. Pathol. 118, 278-287
14. Cotsarelis, G., Sun, T.T. and Lavker, R.M. (1990) Label retaining cells reside in the bulge area of pilosebaceous unit: implications for follicular stem cells, hair cycle, and skin carcinogenesis, Cell 61, 1329
15. Murphy, G.F., Lavker, R.M., Whitaker, D. and Korngold, R. (1991) Cytotoxic folliculitis in acute graft-versus-host disease: evidence of follicular stem cell injury and recovery, J. Cutan. Pathol. 18, 309-314
16. Sale, G.E. and Beauchamp, M. (1993) The parafollicular hair bulge in human GvHD: a stem cell rich primary target, Bone Marrow Transplant. 11, 223-225
17. Sale, G.E., Beauchamp, M.D. and Akiyama, M. (1994) Parafollicular bulge but not hair bulb keratinocytes are attacked in graft vs host disease (GvHD) of human skin, Bone Marrow Transplant. 14, 411-413
18. Beschorner, W.E., Tutschka, P.J. and Santos, G.W. (1982) Chronic graft-versus-host disease in rat radiation chimera. I. Clinical features, hematology, histology, and immunopathology in long-term chimeras. Transplantation 33, 393-399
19. Sale, G.E., Raff, R.F. and Storb, R. (1994) Stem cell regions in filiform papillae of tongue as targets of graft vs host disease, Transplantation 58, 1273-1287
20. Sale, G.E., Farr, A. and Hamilton, B.L. (1991) The murine forestomach: a sensitive site for graft-versus-host disease, Bone Marrow Transplant. 7, 263-267
21. Sale, G.E., Jakic-Razumovic, J. and Hamilton, B.L. (1991) Evidence supporting the prediction that the squamocolumnar junction of murine forestomach is a site of epithelial stem cells, Bone Marrow Transplant. 8, 237-238
22. Sale, G.E. (1986) Ileal predilection of graft-versus-host disease, Lancet ii, 1221
23. Sviland, L. et al. (1989) Expression of MHC class I and II antigens by keratinocytes and enterocytes in acute graft-versus-host disease, Bone Marrow Transplant. 4, 233-238
24. Volc-Platzer, B. et al. (1988) Sequential immunohistologic analysis of the skin following allogeneic bone marrow transplantation, J. Invest. Dermatol. 91, 162-168
25. denHaan, J.M.M. et al. (1995) Identification of a graft-versus-host disease associated human minor histocompatibility antigen, Science 268, 1476-1480
26. Steinmuller, D., Tyler, J.D. and David, C.S. (1981) Cell mediated cytotoxicity to non-MHC alloantigens on mouse epidermal cells, J. Immunol. 126, 1747-1753.
27. Sale, G.E. (1991) Are stem cells attacked in graft-versus-host disease? J. Cutan. Pathol. 18, 305-306
28. Ritz, J.R. et al. (1988) Characterization of functional surface structures on human NK cells, Adv. Immunol. 42, 181-212
29. Keever, C. and Flomenburg, N. (1995) Graft-host tolerance in patients undergoing bone marrow transplantation, in Marrow Transplant Reviews (Sullivan, K.M. and Koppa, S.D., eds), pp. 143-146, Kluge
30. Reusch, M.K., Mansbridge, J.N. and Nickoloff, B.J. (1991) Immunophenotyping of skin cells during healing of suction blister injury, Dermatologica 183, 179-183
31. Lang, R.A. et al. (1993) Macrophages are required for cell death and tissue remodeling in the developing mouse eye, Cell 74, 453-462
32. Ferrara, J. and Deeg, H. (1991) Graft-versus-host disease. Review of mechanisms of disease, New Engl. J. Med. 324, 667-674